DRL files ANDA for Rabeprazole Sodium
Facebook Twitter google+ RSS Feed

DRL files ANDA for Rabeprazole Sodium

By SiliconIndia   |   Thursday, 20 November 2003, 08:00 Hrs
Printer Print Email Email
HYDERABAD: Dr. Reddy's Laboratories today filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA). The ANDAv was filed for Rabeprazole Sodium delayed-release tablets, 20 mg, with a Paragraph IV certification on the two Orange Book patents listed for the drug.

Dr. Reddy's notified Eisai, upon which the latter filed a lawsuit against the company in the United States District Court for the southern district of New York alleging patent infringement on the '552 patent, the release issued to the BSE said.

Experts on SiliconIndia
Santhosh  K
Sr. Soft. Engg.
Oracle India
Nehal Vyas
Sr. Team Lead
Cyberoam Tech.
Rani Malli
Sr. Director
Philips
Sr. Executive
ISB
Vijay Balkrishna Konduskar
Business Consultant
Imans Web Tech
Dr L P  Sharma
Technical Director
NIC
Reena Khanna
Founder
Solitaireworld
Dellas  Asse
sys-network admin
Computer Station
Write your comment now
Submit Reset